Fixed-dose Combination Therapy (PolyPill) in Primary and Secondary Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians

Trial Profile

Fixed-dose Combination Therapy (PolyPill) in Primary and Secondary Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Aspirin/hydrochlorothiazide/enalapril/atorvastatin (Primary)
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms PolyIran
  • Most Recent Events

    • 22 Oct 2012 Planned End Date changed from 1 Aug 2017 to 1 Apr 2018 as reported by ClinicalTrials.gov.
    • 06 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 28 Jan 2011 Planned end date changed from 1 Jul 2017 to 1 Aug 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top